Thymosin Peptide Dosage: What Research and Clinical Trials Show

There is no single thymosin peptide dosage. The right amount depends on which thymosin you mean, the reason it is being studied, and the route of administration. Thymosin alpha-1 is often dosed at 1.6 mg subcutaneously twice weekly in clinical trials, while thymosin beta-4 (TB-500) is used in research settings at roughly 2 to 2.5 mg twice weekly. Neither is FDA-approved for general human use in the United States.

Dosage charts online often mix human trial data with animal data, so read them carefully. A number that appears in one study may not apply to another compound, condition, or delivery method.

Thymosin Alpha-1 Dosage in Clinical Research

Thymosin alpha-1 (Tα1) is a synthetic version of a natural thymic peptide. In clinical trials for chronic hepatitis B, a common dose is 1.6 mg given subcutaneously twice per week for six months. Some cancer studies have used 900 mcg/m² daily or 1.6 mg twice weekly, depending on the protocol.

Thymosin alpha-1 is sometimes sold as immune peptide a2. That label does not change the dosing logic, but it can make product identification harder. Many users research thymosin peptide benefits before they ever consider a dose, yet human data remain limited outside specific conditions.

Thymosin alpha-1 is approved in a few countries outside the United States for certain viral and immune-related conditions. It is not FDA-approved for human use in the United States.

Thymosin Beta-4 (TB-500) Dosage in Research Models

Thymosin beta-4 is a naturally occurring peptide involved in cell migration and tissue repair. TB-500 is a synthetic fragment often studied in animals. Research protocols commonly use 2 to 2.5 mg per dose, given twice weekly by subcutaneous or intramuscular injection.

Some animal studies use 2 to 5 mg per week, sometimes with a loading phase for two to four weeks followed by a lower maintenance dose. These are laboratory doses, not proven human doses.

No country has approved thymosin beta-4 for human therapeutic use. Any human dosage information online is anecdotal or extrapolated from animal research.

Thymosin Peptide Dosage Comparison Table

Peptide	Common research or clinical dose	Route	Frequency	Approval status
Thymosin alpha-1	1.6 mg	Subcutaneous	Twice weekly	Approved in some countries outside the US; not FDA-approved
Thymosin alpha-1	900 mcg/m²	Subcutaneous	Daily in some cancer protocols	Not FDA-approved
Thymosin beta-4 (TB-500)	2–2.5 mg	Subcutaneous or intramuscular	Twice weekly	Not approved for human use
Thymosin beta-4 (TB-500)	2–5 mg per week	Subcutaneous or intramuscular	Split into two doses	Not approved for human use

Factors That Change Thymosin Peptide Dosage

A dose that appears in one study cannot be safely copied to another person. Clinicians adjust based on health status, medications, and lab results.

• Compound: Thymosin alpha-1 and TB-500 have different half-lives, targets, and research histories.
• Indication: Hepatitis B, cancer, wound healing, and immune support use different protocols.
• Route: Subcutaneous, intramuscular, and intravenous routes change bioavailability.
• Body weight: Some trials use mcg/m², so weight matters.
• Frequency and duration: Loading phases, maintenance phases, and treatment length vary.
• Product quality: Purity and concentration can differ between vendors.
• Health status: Kidney function, liver function, and immune status may affect safety.

Safety, Legality, and Medical Guidance

Thymosin peptides are not FDA-approved for human use in the United States. Thymosin alpha-1 has regulatory approval in some other countries, but that does not make it legal or safe for self-dosing in the US.

Potential risks include injection-site reactions, immune system changes, and interactions with other treatments. Long-term safety data in healthy adults are limited.

Anyone considering a thymosin peptide should talk with a licensed healthcare professional. Do not use online dosage charts as a substitute for medical advice.

How to Evaluate Thymosin Peptide Products and Vendors

Product quality is as important as dose. Before buying, compare peptide website reviews and Certificates of Analysis. A reputable seller provides third-party testing for identity, purity, and sterility.

Some sellers, such as Integrative Peptides, offer thymosin products. Reading integrative peptides reviews can reveal whether a seller provides third-party testing and clear labeling.

Look for a batch number, HPLC data, and mass spectrometry results. Avoid vendors that only show a generic COA. Also note that research chemicals are not intended for human use.

A COA should match the batch number on the vial. If a vendor cannot provide that match, treat the product as unverified.

Bottom Line on Thymosin Peptide Dosage

Thymosin peptide dosage is not one-size-fits-all. Thymosin alpha-1 has the most human trial data, usually at 1.6 mg twice weekly, while TB-500 remains a research peptide without approved human dosing.

If you are considering a thymosin peptide, speak with a healthcare professional first. Use verified products, follow legal rules in your country, and never self-inject a research chemical based on an online chart.

RELATED PEPTIDE TOPICTB-500 peptide research

COMMON QUESTIONS

Frequently Asked Questions

What is the standard thymosin peptide dosage?

There is no standard thymosin peptide dosage. Thymosin alpha-1 is often studied at 1.6 mg subcutaneously twice weekly, while TB-500 research uses 2 to 2.5 mg twice weekly. Neither is FDA-approved for general human use in the US.

Is thymosin alpha-1 FDA-approved?

Thymosin alpha-1 is not FDA-approved for human use in the United States. It is approved in some other countries for specific conditions, such as chronic hepatitis B. US buyers should consult a doctor and follow local laws.

Can I buy thymosin peptides online legally?

Legality depends on the peptide and your country. In the US, thymosin alpha-1 and TB-500 are not approved prescription drugs, and importing them for personal use may violate FDA rules. Research chemicals are sold for laboratory use only, not for human consumption.